Literature DB >> 23414056

NMR investigation of the spontaneous thermal- and/or photoinduced reduction of trans dihydroxido Pt(IV) derivatives.

Emanuele Petruzzella1, Nicola Margiotta, Mauro Ravera, Giovanni Natile.   

Abstract

The initial aim of the present work was the synthesis of the axial disuccinato Pt(IV) derivative of [PtCl2(cis-1,4-DACH)] (Kiteplatin, 1 in Figure 1 ) (DACH = diaminocyclohexane), which contains an isomeric form of the diamine ligand present in oxaliplatin (i.e., 1R,2R-DACH). The interest in this compound stems from its activity on several cisplatin and oxaliplatin-resistant cell lines. Oxidation of 1 with hydrogen peroxide affords cis,trans,cis-[PtCl2(OH)2(cis-1,4-DACH)] (2) which was treated with succinic anhydride in suitable solvents. To our surprise, in dimethylformamide (DMF) (50-70 °C or under light irradiation) or in dimethylsulfoxide (DMSO) (under light irradiation) the formation of the succinato complex cis,trans,cis-[PtCl2{OC(O)CH2CH2C(O)OH}2(cis-1,4-DACH)] (3) was accompanied by reduction to 1. It was found that solvolysis of 2 and formation of a μ-oxo dinuclear species (5) is the key step. The dinuclear species can then undergo reduction to a 1:1 mixture of 1 and 2 with concomitant elimination of oxygen (1/2 O2 in the form of H2O2). The whole process is fostered by heat and/or light, which could favor solvolysis of 2 as well as decomposition of hydrogen peroxide to water and oxygen so preventing the reoxidation of 1 to 2. Because of its peculiar behavior, compound 5 could be exploited also for the development of a technology for water splitting.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23414056     DOI: 10.1021/ic302100x

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  5 in total

1.  Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration.

Authors:  Alessandra Barbanente; Valentina Gandin; Cecilia Ceresa; Cristina Marzano; Nicoletta Ditaranto; James D Hoeschele; Giovanni Natile; Fabio Arnesano; Concetta Pacifico; Francesco P Intini; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

2.  Photoinduced reduction of Pt(IV) within an anti-proliferative Pt(IV)-texaphyrin conjugate.

Authors:  Grégory Thiabaud; Jonathan F Arambula; Zahid H Siddik; Jonathan L Sessler
Journal:  Chemistry       Date:  2014-06-24       Impact factor: 5.236

3.  Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position.

Authors:  Salvatore Savino; Nunzio Denora; Rosa Maria Iacobazzi; Letizia Porcelli; Amalia Azzariti; Giovanni Natile; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2016-06-25       Impact factor: 5.923

4.  Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions.

Authors:  Salvatore Savino; Cristina Marzano; Valentina Gandin; James D Hoeschele; Giovanni Natile; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2018-07-14       Impact factor: 5.923

5.  Platinum(IV) Complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs Affording an Oxaliplatin Analogue that Overcomes Cancer Resistance.

Authors:  Paride Papadia; Katia Micoli; Alessandra Barbanente; Nicoletta Ditaranto; James D Hoeschele; Giovanni Natile; Cristina Marzano; Valentina Gandin; Nicola Margiotta
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.